Mariana Castanheira

Mariana Castanheira is a Brazilian microbiologist who is the Chief Scientific Officer at JMI Laboratories. Her research considers antimicrobial surveillance and the design. She was elected Fellow of the American Society for Microbiology in 2023. Provided by Wikipedia
Showing 1 - 20 results of 28 for search 'Mariana Castanheira', query time: 0.06s Refine Results
  1. 1
    Meropenem-Vaborbactam Activity against U.S. Multidrug-Resistant Enterobacterales Strains, Including Carbapenem-Resistant Isolates

    Meropenem-Vaborbactam Activity against U.S. Multidrug-Resistant Enterobacterales Strains, Including Carbapenem-Resistant Isolates by Dee Shortridge, Valerie Kantro, Mariana Castanheira

    Published 2023-02-01
    Get full text
    Article
  2. 2
    In Vitro Activity of Cefiderocol against U.S. and European Gram-Negative Clinical Isolates Collected in 2020 as Part of the SENTRY Antimicrobial Surveillance Program

    In Vitro Activity of Cefiderocol against U.S. and European Gram-Negative Clinical Isolates Collected in 2020 as Part of the SENTRY Antimicrobial Surveillance Program by Dee Shortridge, Jennifer M. Streit, Rodrigo Mendes, Mariana Castanheira

    Published 2022-04-01
    Get full text
    Article
  3. 3
    In Vitro Antimicrobial Activity of Taurolidine against Isolates Associated with Catheter-Related Bloodstream Infections

    In Vitro Antimicrobial Activity of Taurolidine against Isolates Associated with Catheter-Related Bloodstream Infections by Jared Crandon, S.J. Ryan Arends, Paul Rhomberg, Mariana Castanheira

    Published 2024-07-01
    Get full text
    Article
  4. 4
    Trends in the susceptibility of U.S. Acinetobacter baumannii-calcoaceticus species complex and Stenotrophomonas maltophilia isolates to minocycline, 2014–2021

    Trends in the susceptibility of U.S. Acinetobacter baumannii-calcoaceticus species complex and Stenotrophomonas maltophilia isolates to minocycline, 2014–2021 by Michael A. Pfaller, Dee Shortridge, Cecilia G. Carvalhaes, Mariana Castanheira

    Published 2023-12-01
    Get full text
    Article
  5. 5
    Antimicrobial susceptibility of enterobacterales causing bloodstream infection in United States medical centres: comparison of aztreonam-avibactam with beta-lactams active against carbapenem-resistant enterobacterales

    Antimicrobial susceptibility of enterobacterales causing bloodstream infection in United States medical centres: comparison of aztreonam-avibactam with beta-lactams active against... by Helio S. Sader, John H. Kimbrough, Rodrigo E. Mendes, Mariana Castanheira

    Published 2024-11-01
    Get full text
    Article
  6. 6
    Antimicrobial activities of ceftazidime/avibactam, ceftolozane/tazobactam, imipenem/relebactam, meropenem/vaborbactam, and comparators against Pseudomonas aeruginosa from patients with skin and soft tissue infections

    Antimicrobial activities of ceftazidime/avibactam, ceftolozane/tazobactam, imipenem/relebactam, meropenem/vaborbactam, and comparators against Pseudomonas aeruginosa from patients... by Helio S. Sader, Mariana Castanheira, Leonard R. Duncan, Rodrigo E. Mendes

    Published 2021-12-01
    Get full text
    Article
  7. 7
    Performance of the Vitek 2 Advanced Expert System (AES) as a Rapid Tool for Reporting Antimicrobial Susceptibility Testing (AST) in Enterobacterales from North and Latin America

    Performance of the Vitek 2 Advanced Expert System (AES) as a Rapid Tool for Reporting Antimicrobial Susceptibility Testing (AST) in Enterobacterales from North and Latin America by Cecilia G. Carvalhaes, Dee Shortridge, Leah N. Woosley, Nabina Gurung, Mariana Castanheira

    Published 2023-02-01
    Get full text
    Article
  8. 8
    Activity of Aztreonam/Avibactam and Recently Approved β-Lactamase Inhibitor Combinations against Enterobacterales and <i>Pseudomonas aeruginosa</i> from Intensive Care Unit and Non-Intensive Care Unit Patients

    Activity of Aztreonam/Avibactam and Recently Approved β-Lactamase Inhibitor Combinations against Enterobacterales and <i>Pseudomonas aeruginosa</i> from Intensive Care Unit and Non... by Helio S. Sader, Rodrigo E. Mendes, John H. Kimbrough, Cory M. Hubler, Mariana Castanheira

    Published 2024-06-01
    Get full text
    Article
  9. 9
    Vaborbactam increases meropenem susceptibility in Pseudomonas aeruginosa clinical isolates displaying MexXY and AmpC upregulation

    Vaborbactam increases meropenem susceptibility in Pseudomonas aeruginosa clinical isolates displaying MexXY and AmpC upregulation by Mariana Castanheira, Timothy B. Doyle, Cory M. Hubler, Sean DeVries, Dee Shortridge

    Published 2023-10-01
    Get full text
    Article
  10. 10
    Activity of meropenem/vaborbactam against international carbapenem-resistant Escherichia coli isolates in relation to clonal background, resistance genes, resistance to comparators and region

    Activity of meropenem/vaborbactam against international carbapenem-resistant Escherichia coli isolates in relation to clonal background, resistance genes, resistance to comparators... by Brian D. Johnston, Paul Thuras, Stephen B. Porter, Mariana Castanheira, James R. Johnson

    Published 2021-03-01
    Get full text
    Article
  11. 11
    In vitro activity assessment of cefiderocol against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp., including β-lactam nonsusceptible molecularly characterized isolates, collected from 2020 to 2021 in the United States and European hospitals

    In vitro activity assessment of cefiderocol against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp., including β-lactam nonsusceptible molecularly characterized is... by John H. Kimbrough, Joshua M. Maher, Helio S. Sader, Mariana Castanheira, Rodrigo E. Mendes

    Published 2024-11-01
    Get full text
    Article
  12. 12
    Antimicrobial susceptibility of clinical isolates of Stenotrophomonas maltophilia isolates from Europe, Asia, and Latin America (2018-2023)

    Antimicrobial susceptibility of clinical isolates of Stenotrophomonas maltophilia isolates from Europe, Asia, and Latin America (2018-2023) by Helio S. Sader, Rodrigo E. Mendes, Timothy B. Doyle, Marisa L. Winkler, Mariana Castanheira

    Published 2025-04-01
    Get full text
    Article
  13. 13
    Activity of Ceftolozane-Tazobactam Against Gram-Negative Isolates from Australia and New Zealand as part of the PACTS Surveillance 2016-2018

    Activity of Ceftolozane-Tazobactam Against Gram-Negative Isolates from Australia and New Zealand as part of the PACTS Surveillance 2016-2018 by Dee Shortridge, Jennifer Streit, Michael Pfaller, Merrin Tulloch, Wei-Ting Chen, Mariana Castanheira

    Published 2022-12-01
    Get full text
    Article
  14. 14
    Activity of Aztreonam-avibactam and other β-lactamase inhibitor combinations against Gram-negative bacteria isolated from patients hospitalized with pneumonia in United States medical centers (2020–2022)

    Activity of Aztreonam-avibactam and other β-lactamase inhibitor combinations against Gram-negative bacteria isolated from patients hospitalized with pneumonia in United States medi... by Helio S. Sader, Rodrigo E. Mendes, S. J. Ryan Arends, Timothy B. Doyle, Mariana Castanheira

    Published 2025-01-01
    Get full text
    Article
  15. 15
    Antifungal Activity of Isavuconazole and Comparator Agents against Contemporaneous Mucorales Isolates from USA, Europe, and Asia-Pacific

    Antifungal Activity of Isavuconazole and Comparator Agents against Contemporaneous Mucorales Isolates from USA, Europe, and Asia-Pacific by Cecilia G. Carvalhaes, Paul R. Rhomberg, Michael D. Huband, Michael A. Pfaller, Mariana Castanheira

    Published 2023-02-01
    Get full text
    Article
  16. 16
    In Vitro Activity of Isavuconazole and Other Mould-Active Azoles against <i>Aspergillus fumigatus</i> with and without CYP51 Alterations

    In Vitro Activity of Isavuconazole and Other Mould-Active Azoles against <i>Aspergillus fumigatus</i> with and without CYP51 Alterations by Michael A. Pfaller, Cecilia G. Carvalhaes, Lalitagauri M. Deshpande, Paul R. Rhomberg, Mariana Castanheira

    Published 2023-05-01
    Get full text
    Article
  17. 17
    Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Latin America: report from an antimicrobial surveillance program (2013–2015)

    Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Latin America: report from an antim... by Michael A. Pfaller, Dee Shortridge, Helio S. Sader, Ana Gales, Mariana Castanheira, Robert K. Flamm

    Published 2017-11-01
    Get full text
    Article
  18. 18
    Azole resistance in Candida glabrata clinical isolates from global surveillance is associated with efflux overexpression

    Azole resistance in Candida glabrata clinical isolates from global surveillance is associated with efflux overexpression by Mariana Castanheira, Lalitagauri M. Deshpande, Andrew P. Davis, Cecilia G. Carvalhaes, Michael A. Pfaller

    Published 2022-06-01
    Get full text
    Article
  19. 19
    Antimicrobial activity of manogepix, a first-in-class antifungal, and comparator agents tested against contemporary invasive fungal isolates from an international surveillance programme (2018–2019)

    Antimicrobial activity of manogepix, a first-in-class antifungal, and comparator agents tested against contemporary invasive fungal isolates from an international surveillance prog... by Michael A. Pfaller, Michael D. Huband, Robert K. Flamm, Paul A. Bien, Mariana Castanheira

    Published 2021-09-01
    Get full text
    Article
  20. 20
    Contemporary Evaluation of Tebipenem In Vitro Activity against Enterobacterales Clinical Isolates Causing Urinary Tract Infections in US Medical Centers (2019–2020)

    Contemporary Evaluation of Tebipenem In Vitro Activity against Enterobacterales Clinical Isolates Causing Urinary Tract Infections in US Medical Centers (2019–2020) by Rodrigo E. Mendes, S. J. Ryan Arends, Jennifer M. Streit, Ian Critchley, Nicole Cotroneo, Mariana Castanheira

    Published 2023-02-01
    Get full text
    Article

Search Tools: